Search

Meeting Program

Coming soon - The meeting program is under development; stay tuned for the latest updates here.

Read more

Adolescents and young adults (AYA)

Spotlight on AYAAdolescents and young adults (AYA) with hematologic diseases are a unique group with special characteristics and needs. In recent years, the challenges related to the management of AYA (particularly in relation to cancer) have increasingly been recognized.

Read more

Substances of Human Origin (SoHO) legislation

EHA’s involvementEHA has been involved in both the evaluation and subsequent revision of the EU legislation on human blood and blood components. The evaluation of these rules, which dated back to 2002, began in 2016.

Read more

Presentations

The presentations will be shared soon.

Read more

Advocacy priorities

The European Union works on countless pieces of legislation and policies that affect the health ecosystem. Some are relevant to most medical disciplines, including hematology—such as the legislation on health data or pharmaceuticals.

Read more

EU funding calls for hematology

Horizon Europe
MSCA Feedback to Policy 2024 (deadline: September 4, 2024)
MSCA International Cooperation 2024 (deadline: September 4, 2024)
MSCA Postdoctoral Fellowship 2024 (deadline: September 11, 2024)
Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer (deadline: September…

Read more

Regulatory affairs & scientific relations

EHA’s regulatory work: European Medicines AgencyMost of EHA’s regulatory work entails collaboration with the European Medicines Agency (EMA).

Read more

Alliances & partnerships

EHA's approach to policy and regulatory affairs involves collaboration across medical professions and disciplines.

Read more